2. Academic Validation
  3. Optimizing Linezolid: Transforming It into a Selective MAO-B Inhibitor via a Toxicity-to-Activity Optimization Approach

Optimizing Linezolid: Transforming It into a Selective MAO-B Inhibitor via a Toxicity-to-Activity Optimization Approach

  • ACS Med Chem Lett. 2024 Dec 16;16(1):40-50. doi: 10.1021/acsmedchemlett.4c00354.
Mayur S Dhangar 1,  Iqrar Ahmad 1,  Jong Min Oh 2,  Bhatu R Patil 1,  Sampath Chinnam 3,  Dharmarajan Sriram 4,  Jyothi Kumari 4,  Bijo Mathew 5,  Rais A Sayyed 1,  Shubham B Chaudhari 6,  Siddique Akber Ansari 7,  Nishant Rai 8 9,  Hoon Kim 2,  Harun M Patel 1
Affiliations

Affiliations

  • 1 Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 425405, India.
  • 2 Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea.
  • 3 Department of Chemistry, M. S. Ramaiah Institute of Technology (Autonomous Institute, Affiliated to Visvesvaraya Technological University, Belgaum), Bengaluru, Karnataka 560054, India.
  • 4 Department of Pharmacy, Birla Institute of Technology and Science-Pilani, Hyderabad Campus, Jawahar Nagar, Shameerpet Mandal, R. R. District, Hyderabad, Telagana 500078, India.
  • 5 Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi 690525, India.
  • 6 Department of Pharmaceutical Technology and Process Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Mohali, Punjab 160002, India.
  • 7 Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • 8 Graphic Era (Deemed to be University), Clement Town, Dehradun 248002, India.
  • 9 Graphic Era Hill University, Clement Town, Dehradun 248002, India.
PMID: 39811132 DOI: 10.1021/acsmedchemlett.4c00354
Abstract

Linezolid, a widely used Oxazolidinone antibiotic, exhibits potent activity against resistant Bacterial infections but is associated with serotonergic toxicity, primarily due to its inhibition of Monoamine Oxidase (MAO). MAOs, consisting of MAO-A and MAO-B isoforms, play crucial roles in neurotransmitter metabolism, with implications for neurodegenerative disorders like Parkinson's and Alzheimer's diseases. This study aims to optimize Linezolid's structure to transform it into a selective MAO-B Inhibitor. Utilizing structure-activity and structure-toxicity relationship approaches, novel analogues of Linezolid were synthesized by replacing its Oxazolidinone ring with a thiadiazole scaffold. Among the synthesized compounds, 6b emerged as a lead candidate, displaying a remarkable MAO-B inhibitory activity (IC50 = 0.03 μM) and 464-fold selectivity over MAO-A, compared to the standard drugs Pargyline (IC50 = 0.14 μM) and Clorgyline (IC50 = 1.85 μM). Furthermore, docking and molecular dynamics simulations corroborated the high affinity and stability of compound 6b in the MAO-B enzyme's binding pocket. These findings suggest that optimized Linezolid analogues, particularly compound 6b, hold promise as selective MAO-B inhibitors, offering therapeutic potential for treating neurodegenerative diseases while avoiding the risks associated with serotonergic toxicity.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z